Extra-Label Communication Could Foster Novel Switch NDAs – Industry Attorney
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has several avenues to foster more novel Rx-to-OTC switches, including allowing extra-label communications beyond the packaging, similar to dispensing labeling used by a pharmacist, to be part of an approval.